Know Cancer

or
forgot password


Phase 2
18 Years
N/A
Not Enrolling
Both
Carcinoma, Hepatocellular

Thank you

Trial Information


Inclusion Criteria:



- Patients with definite diagnosis of HCC based on a Dynamic MRI revealing a vascular
mass in the liver and histologic confirmation of HCC.

- Patients who are not candidates for surgical resection, OLT or radiofrequency
ablation.

- Patients with no prior treatment for HCC.

- Patients with extrahepatic spread and/or vascular invasion are permissible.

Type of Study:

Interventional

Study Design:

Masking: Open Label, Primary Purpose: Treatment

Authority:

United States: Federal Government

Study ID:

NCRR-M01RR00042-1707

NCT ID:

NCT00006332

Start Date:

Completion Date:

Related Keywords:

  • Carcinoma, Hepatocellular
  • Molybdenum
  • Carcinoma
  • Carcinoma, Hepatocellular

Name

Location

3912 Taubman CenterAnn Arbor, Michigan  48109-0362